A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE) (Q65394919)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE) |
clinical trial |
Statements
A Randomized, Double-Blind, Placebo-Controlled, Parallel- Group, Phase 2 Study of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE) (English)
0 references
24 March 2016
0 references
12 October 2017
0 references
314
0 references
18 year
0 references